Dr Iris Bartula

DCP
Senior Lecturer, Northern Sydney Medical School.

Telephone (02) 9911 7398

Website Melanoma Institute Australia
Melanoma Centre of Research Excellence
Curriculum vitae Curriculum vitae

Map

Biographical details

Dr Iris Bartula is a Senior Lecturer at University of Sydney. She is a head of psychosocial research at Melanoma Institute Australia (MIA), where she is leading the Support and Survivorship theme. Dr Bartula is passionate about improving quality of life of melanoma patients, as well as integrating psychosocial support into a routine medical practice. To this end, she is leading research at MIA that will: (1) create and disseminate knowledge; (2) translate the evidence; and, (3) increase the capacity of psychosocial research at MIA.

Dr Bartula obtained Bachelor of Psychology (Honours) degree in 2003 from University of Sydney. She then practiced as a psychologist in a large state government department until 2011, when she returned to university to obtain her post-graduate degree. Dr Bartula completed Doctorate of Clinical Psychology / Masters of Philosophy at Macquarie University in 2015. Her research focused on the assessment of sexual dysfunction in women diagnosed with breast cancer. She was awarded Australian Psychological Society Clinical Psychologists Student Prize in 2016.

Research interests

Dr Bartula is passionate about researching issues affecting people diagnosed with melanoma across their cancer journey - from diagnosis, treatment, survivorship, palliative care and end of life. In particular, her research interests include:

  • Assessment of psychosocial functioning and quality of life
  • Interventions targeting distress and psychological disorders
  • Assessment and interventions implementation into routine practice
  • Addressing the needs of oncology professionals
  • Assessing quality of life impacts of medical treatments

Current projects

  • Assessing feasibility and acceptability of embedding electronic Patient Outcome Measures (ePROM) and Patient Experience Measures (ePREM) into routine care of Stage III melanoma patients
  • Quality of life impact of nivolumaband ipilimumab or nivolumab alone in patients with melanoma with brain metastases
  • Investigating barriers for accepting psychosocial support
  • Investigating the feasibility in implementing stepped-care approach in treating psychological distress in patients diagnosed with melanoma
  • Investigating the most cost-effective models od psychosocial care for melanoma patients

Associations

  • Australian Health Practitioners Registration Agency (AHPRA) registered psychologist with Clinical Psychology endorsement
  • AHPRA board-approved supervisor for 4+2, 5+1, Masters of Clinical Psychology students (primary), Clinical Psychology Registrars (secondary)
  • Member of Australian Psychological Society (APS)
  • Fellow of the APS Clinical Psychologists College

Awards and honours

  • 2016 Australian Psychological Society Clinical Psychologists Student Prize

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Bartula, I., Sherman, K. (2015). Development and validation of the Female Sexual Function Index adaptation for breast cancer patients (FSFI-BC). Breast Cancer Research and Treatment, 152, 477-488. [More Information]
  • Bartula, I., Sherman, K. (2015). Development and validation of the Female Sexual Function Index adaptation for breast cancer patients (FSFI-BC). Breast Cancer Research and Treatment, 152(3), 477-488. [More Information]
  • Bartula, I., Sherman, K. (2015). The Female Sexual Functioning Index (FSFI): evaluation of acceptability, reliability, and validity in women with breast cancer. Supportive Care in Cancer, 23, 2633-2641. [More Information]
  • Bartula, I., Sherman, K. (2015). The Female Sexual Functioning Index (FSFI): evaluation of acceptability, reliability, and validity in women with breast cancer. Supportive Care in Cancer, 23(9), 2633-2641. [More Information]
  • Bartula, I., Sherman, K. (2013). Screening for sexual dysfunction in women diagnosed with breast cancer: systematic review and recommendations. Breast Cancer Research and Treatment, 141, 173-185. [More Information]
  • Bartula, I., Sherman, K. (2013). Screening for sexual dysfunction in women diagnosed with breast cancer: Systematic review and recommendations. Breast Cancer Research and Treatment, 141(2), 173-185. [More Information]

2015

  • Bartula, I., Sherman, K. (2015). Development and validation of the Female Sexual Function Index adaptation for breast cancer patients (FSFI-BC). Breast Cancer Research and Treatment, 152, 477-488. [More Information]
  • Bartula, I., Sherman, K. (2015). Development and validation of the Female Sexual Function Index adaptation for breast cancer patients (FSFI-BC). Breast Cancer Research and Treatment, 152(3), 477-488. [More Information]
  • Bartula, I., Sherman, K. (2015). The Female Sexual Functioning Index (FSFI): evaluation of acceptability, reliability, and validity in women with breast cancer. Supportive Care in Cancer, 23, 2633-2641. [More Information]
  • Bartula, I., Sherman, K. (2015). The Female Sexual Functioning Index (FSFI): evaluation of acceptability, reliability, and validity in women with breast cancer. Supportive Care in Cancer, 23(9), 2633-2641. [More Information]

2013

  • Bartula, I., Sherman, K. (2013). Screening for sexual dysfunction in women diagnosed with breast cancer: systematic review and recommendations. Breast Cancer Research and Treatment, 141, 173-185. [More Information]
  • Bartula, I., Sherman, K. (2013). Screening for sexual dysfunction in women diagnosed with breast cancer: Systematic review and recommendations. Breast Cancer Research and Treatment, 141(2), 173-185. [More Information]

To update your profile click here. For support on your academic profile contact .